MenB vaccine programme cuts cases of meningitis and septicaemia in infantsBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4839 (Published 07 September 2016) Cite this as: BMJ 2016;354:i4839
- Jacqui Wise
The number of cases of meningitis and septicaemia caused by meningococcal group B infection in infants has halved since the introduction of a new vaccine last year, Public Health England reports.1
All newborn babies in the United Kingdom are now routinely offered the vaccination against meningococcal group B, the world’s first infant programme to use this vaccine. In the 10 months since the programme began only 37 recorded cases of meningococcal B were recorded in infants aged under 1, compared with an average of 74 in the same …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.